Hongbing Duan

机构：Shandong University, University of Jinan, Peng Cheng Laboratory, Northwest A&F University

发表论文 29 篇 · 总被引 515 次 · h-index 12

代表论文

• Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma (2014 · Molecular Biology Reports · 被引 86)
• Effect of PVC microplastics on soil microbial community and nitrogen availability under laboratory-controlled and field-relevant temperatures (2022 · Applied Soil Ecology · 被引 59)
• Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis (2022 · Annals of Surgical Oncology · 被引 36)
• Thoracoscopy-Assisted Minimally Invasive Surgical Stabilization of the Anterolateral Flail Chest Using Nuss Bars (2014 · The Annals of Thoracic Surgery · 被引 29)
• Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial (2021 · 癌症：英文版 · 被引 25)
• Comparison of efficacy and safety between neoadjuvant chemotherapy and neoadjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis (2023 · International Journal of Surgery · 被引 21)